Open Access. Powered by Scholars. Published by Universities.®
Biomedical Engineering and Bioengineering Commons™
Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Biomedical Engineering and Bioengineering
In Vitro Activity Of Levofloxacin, Singly And In Combination With Rifamycin Analogs, Against Mycobacterium Leprae, Arvind Madhav Dhople, Maria Antonia Ibáñez
In Vitro Activity Of Levofloxacin, Singly And In Combination With Rifamycin Analogs, Against Mycobacterium Leprae, Arvind Madhav Dhople, Maria Antonia Ibáñez
Biomedical Engineering and Sciences Faculty Publications
The in vitro susceptibility of Mycobacterium leprae to levofloxacin was studied by using two biochemical parameters to measure the metabolic activity of the organism. Levofloxacin consistently exhibited twofold greater bactericidal activity than ofloxacin, with the MIC being 0.75 μg/ml. When combined with one of the three rifamycin analogs, synergism was obtained with KRM-1648 and rifabutin but not with rifampin.